CHAC1 and chronic kidney disease: These results demonstrated that knockdown of CHAC1 could enhance the improvement effect of SQJZ capsule on intestinal inflammation, suggesting CHAC1 may be the target of SQJZ capsule in CKD-associated intestinal inflammation.